August 8, 2019 All of us here at LRA congratulate Daemion T. Johnson – GSK’s Director, Patient Engagement. He was named one of the PharmaVOICE 100 by the magazine PharmaVOICE.com. This list recognizes 100 men and women in the life-sciences industry who “provide inspiration to their peers, colleagues, and companies through their innovative and motivational […] READ MORE
August 7, 2019 Dr. Chandra Mohan discovered that blood clotting proteins are higher in the urine of people with lupus nephritis, announced University of Houston. His work showed that both proteins that promote clotting and those that work to dissolve them are involved. He began examining these proteins because people with lupus and lupus nephritis […] READ MORE
August 8, 2019 In five pilot cities, people with lupus who are thinking about taking part in a clinical trial can now join LRA’s Patient Advocates for Lupus Studies (PALS) program created by our affiliate Lupus Therapeutics. The program will pair adults with lupus interested in learning about clinical trials with a peer or “PAL” who […] READ MORE
August 5, 2019 A new study conducted at Hospital for Special Surgery (HSS) showed that the PROMIS® (Patient-Related Outcomes Measurement Information System) health survey can be used to measure and monitor patients’ experience of lupus that are not captured by standard questionnaires. Researchers gave 223 people with lupus who get their outpatient care at HSS […] READ MORE
August 1, 2019 A new study by LRA Distinguished Innovator Award recipient Dr. Douglas Green of St. Jude Children’s Research Hospital in Memphis, TN, and colleagues may have uncovered a new way to treat Alzheimer’s disease. The research, highlighted recently in Forbes magazine and published in the journal Cell, identified one of the brain’s mechanisms […] READ MORE
August 1, 2019 The Lupus Research Alliance (LRA), the largest private funder of lupus research in the world, is very pleased to announce a unique new partnership with Celgene Corporation that provides $3,000,000 for bold cutting-edge research projects. This opportunity will focus on understanding the underlying mechanisms of disease, addressing lupus heterogeneity — how much […] READ MORE
July 30, 2019 Resolve Therapeutics announced that it has enrolled enough patients to conduct a Phase 2a study of a potential treatment for lupus, RSLV-132. Grant support from the Lupus Research Alliance to Dr. Keith Elkon of the University of Washington supported the early work that led to the creation of the molecule RSLV-132. In lupus, […] READ MORE
July 30, 2019 Progentec Diagnostics announced it has been awarded a Fast-Track Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) for new biomarker research. The grant has the potential to provide $1.7 million in resources supporting clinical research to see how well lab tests based on biomarkers in the blood […] READ MORE
July 18, 2019 A new study published in The British Journal of Dermatology provides evidence that fatigue is a key symptom, not only of systemic lupus erythematosus (SLE) but also of skin lupus (cutaneous lupus) as well as other autoimmune diseases affecting the skin. Led by an LRA-funded researcher Victoria Werth, MD, the study team […] READ MORE
New York, NY, July 18, 2019 — Renowned Dr. Daniel Wallace joined the Lupus Research Alliance (LRA) affiliate Lupus Therapeutics Board of Directors. This governing body, which includes lupus patients, family members and scientists, provides strategic insight and financial oversight to help Lupus Therapeutics achieve its mission –accelerate new ways to diagnose and treat lupus. READ MORE
July 12, 2019 In years past, doctors had advised most women with lupus to avoid getting pregnant because of the high risk for both mother and fetus. A newly published study in Annals of Internal Medicine by Dr. Bella Mehta shows that more women with lupus are having successful pregnancies, while the accompanying editorial by […] READ MORE
July 11, 2019 The annual meeting of the Federation of Clinical Immunology Societies (FOCIS) is the key forum for translational immunology. The Lupus Research Alliance (LRA) is proud to co-sponsor this meeting, which allows researchers and clinicians to share knowledge across disease borders and to chart the path to the next major breakthroughs in disease […] READ MORE
